• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

大鼠腹膜肥大细胞免疫损伤的机制。II. 补体需求及膦酸酯对兔抗大鼠γ球蛋白所致组胺释放的抑制作用

Mechanisms of immunologic injury of rat peritoneal mast cells. II. Complement requirement and phosphonate ester inhibition of release of histamine by rabbit anti-rat gamma globulin.

作者信息

Austen K F, Becker E L

出版信息

J Exp Med. 1966 Sep 1;124(3):397-416. doi: 10.1084/jem.124.3.397.

DOI:10.1084/jem.124.3.397
PMID:4162486
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2138227/
Abstract

There is an absolute requirement for C'1, C'2, C'4, C'3, and C'5 in releasing histamine from rat peritoneal mast cells sensitized with rabbit anti-rat gamma globulin. This conclusion is based upon the restoration of histamine-releasing capacity by adding highly purified complement components to sera deficient in one or more of these components. Of special advantage was the availability of sera from humans with inborn or acquired deficiencies in a single component. The p-nitrophenyl ethyl phosphonates block this reaction by inhibiting an antigen-antibody-activated esterase which exists in a phosphonate resistant precursor state until activated by the interaction of the sensitized mast cell and serum complement. There is almost complete disparity between the ability of the phosphonates to inhibit complement-dependent histamine release by rabbit anti-RGG and to inactivate C'1a. Even though C'1a is required for complement-dependent histamine release by rabbit anti-RGG, this is not the esterase being blocked by the phosphonates under the experimental conditions used. The pattern of inhibition by the phosphonates of the antigen-antibody-activated esterase required for complement-dependent, noncytotoxic histamine release is remarkably similar to that of the esterase required for homocytotropic antibody-mediated histamine release. One possible implication is that these two quite different modes of carrying out antigen-antibody-induced histamine release from rat peritoneal mast cells lead to activation of the same esterase and share a common pathway.

摘要

从用兔抗大鼠γ球蛋白致敏的大鼠腹膜肥大细胞中释放组胺,绝对需要C'1、C'2、C'4、C'3和C'5。这一结论是基于向缺乏这些成分中一种或多种的血清中添加高度纯化的补体成分后,组胺释放能力得以恢复而得出的。特别有利的是可获得在单一成分上有先天性或后天性缺陷的人的血清。对硝基苯乙基膦酸酯通过抑制一种抗原抗体激活的酯酶来阻断这一反应,这种酯酶以膦酸酯抗性前体状态存在,直到被致敏肥大细胞与血清补体的相互作用激活。膦酸酯抑制兔抗RGG引起的补体依赖性组胺释放的能力与使C'1a失活的能力之间几乎完全不同。尽管兔抗RGG引起的补体依赖性组胺释放需要C'1a,但在所用实验条件下,这不是被膦酸酯阻断的酯酶。膦酸酯对补体依赖性、无细胞毒性组胺释放所需的抗原抗体激活酯酶的抑制模式与亲同种细胞抗体介导的组胺释放所需的酯酶的抑制模式非常相似。一个可能的暗示是,这两种从大鼠腹膜肥大细胞进行抗原抗体诱导组胺释放的截然不同的方式导致了同一种酯酶的激活并共享一条共同途径。

相似文献

1
Mechanisms of immunologic injury of rat peritoneal mast cells. II. Complement requirement and phosphonate ester inhibition of release of histamine by rabbit anti-rat gamma globulin.大鼠腹膜肥大细胞免疫损伤的机制。II. 补体需求及膦酸酯对兔抗大鼠γ球蛋白所致组胺释放的抑制作用
J Exp Med. 1966 Sep 1;124(3):397-416. doi: 10.1084/jem.124.3.397.
2
Mechanisms of immunologic injury of rat peritoneal mast cells. I. The effect of phosphonate inhibitors on the homocytotropic antibody-mediated histamine release and the first component of rat complement.大鼠腹膜肥大细胞免疫损伤机制。I. 膦酸盐抑制剂对亲同种细胞抗体介导的组胺释放及大鼠补体第一成分的影响。
J Exp Med. 1966 Sep 1;124(3):379-95. doi: 10.1084/jem.124.3.379.
3
Complement as a mediator of inflammation. 3. Purification of the activity with anaphylatoxin properties generated by interaction of the first four components of complement and its identification as a cleavage product of C'3.补体作为炎症介质。3. 具有过敏毒素特性的活性物质的纯化,该活性物质由补体前四种成分相互作用产生,并鉴定为C'3的裂解产物。
J Exp Med. 1967 Dec 1;126(6):1027-48. doi: 10.1084/jem.126.6.1027.
4
THE ROLE OF THE COMPONENTS OF COMPLEMENT IN SPECIFIC IMMUNE FIXATION.补体成分在特异性免疫固定中的作用。
J Exp Med. 1942 Apr 1;75(4):421-35. doi: 10.1084/jem.75.4.421.
5
Complement as a mediator of inflammation. II. Biological properties of anaphylatoxin prepared with purified components of human complement.补体作为炎症介质。II. 用人补体纯化成分制备的过敏毒素的生物学特性。
J Exp Med. 1967 May 1;125(5):921-46. doi: 10.1084/jem.125.5.921.
6
A COMPARISON OF THE SPECIFICITY OF INHIBITION BY PHOSPHONATE ESTERS OF THE FIRST COMPONENT OF COMPLEMENT AND THE ANTIGEN-INDUCED RELEASE OF HISTAMINE FROM GUINEA PIG LUNG.膦酸酯对补体第一成分抑制特异性与抗原诱导豚鼠肺组织组胺释放的比较
J Exp Med. 1964 Oct 1;120(4):491-506. doi: 10.1084/jem.120.4.491.
7
Studies on immune cellular injury. II. Functional role of C'1 esterase in immune cytotoxicity.免疫细胞损伤的研究。II. C'1酯酶在免疫细胞毒性中的功能作用。
J Exp Med. 1960 Dec 1;112(6):1107-20. doi: 10.1084/jem.112.6.1107.
8
STUDIES ON IMMUNE HUMAN HEMOLYSIS : II. THE DONATH-LANDSTEINER REACTION AS A MODEL SYSTEM FOR STUDYING THE MECHANISM OF ACTION OF COMPLEMENT AND THE ROLE OF C'1 AND C'1 ESTERASE.免疫性人体溶血的研究:Ⅱ.作为研究补体作用机制和 C'1 和 C'1 酯酶作用的模型系统的唐纳特-兰德施泰纳反应。
J Exp Med. 1961 Jan 1;113(1):193-218. doi: 10.1084/jem.113.1.193.
9
COMPLEMENT AND HEMOLYTIC ANTIBODY: CHANGES IN THEIR ACTIVITY INDUCED BY MERCAPTOETHANOL.补体与溶血抗体:巯基乙醇诱导的其活性变化
Science. 1965 Feb 12;147(3659):742-3. doi: 10.1126/science.147.3659.742.
10
Effect of C'1 esterase on vascular permeability in man: studies in normal and complement-deficient individuals and in patients with hereditary angioneurotic edema.C'1酯酶对人体血管通透性的影响:在正常个体、补体缺陷个体及遗传性血管性水肿患者中的研究。
J Clin Invest. 1968 Mar;47(3):604-11. doi: 10.1172/JCI105756.

引用本文的文献

1
Histamine-releasing factor generated by the interaction of endotoxin with hamster serum.由内毒素与仓鼠血清相互作用产生的组胺释放因子。
Infect Immun. 1970 Oct;2(4):462-7. doi: 10.1128/iai.2.4.462-467.1970.
2
Esterases of the polymorphonuclear leukocyte capable of hydrolyzing acetyl DL-phenyl-alanine beta-naphthyl ester. Relationship to the activatable esterase of chemotaxis.能够水解乙酰 DL - 苯丙氨酸β - 萘酯的多形核白细胞酯酶。与趋化性可激活酯酶的关系。
J Exp Med. 1969 Mar 1;129(3):569-84. doi: 10.1084/jem.129.3.569.
3
The role of the complement system in the pathogenesis of acute pulmonary oedema produced by nephrotoxic serum in rats.补体系统在大鼠肾毒性血清所致急性肺水肿发病机制中的作用。
Clin Exp Immunol. 1970 Mar;6(3):395-406.
4
The requirement of serine esterase function in complement-dependent erythrophagocytosis.补体依赖性红细胞吞噬作用中丝氨酸酯酶功能的需求。
J Exp Med. 1969 Oct 1;130(4):745-64. doi: 10.1084/jem.130.4.745.
5
Complement as a mediator of inflammation. II. Biological properties of anaphylatoxin prepared with purified components of human complement.补体作为炎症介质。II. 用人补体纯化成分制备的过敏毒素的生物学特性。
J Exp Med. 1967 May 1;125(5):921-46. doi: 10.1084/jem.125.5.921.
6
Human reagins: appraisal of the properties of the antibody of immediate-type hypersensitivity.人反应素:速发型超敏反应抗体特性的评估
Bacteriol Rev. 1972 Sep;36(3):311-60. doi: 10.1128/br.36.3.311-360.1972.
7
Mechanisms of the inhibition of chemotaxis by phosphonate esters.膦酸酯抑制趋化作用的机制。
J Exp Med. 1967 Jun 1;125(6):1001-20. doi: 10.1084/jem.125.6.1001.
8
Antibodies involved in antigen-induced release of slow reacting substance of anaphylaxis (SRS-A) in the guinea pig and rat.参与豚鼠和大鼠体内抗原诱导的过敏反应慢反应物质(SRS-A)释放的抗体。
J Exp Med. 1967 Jan 1;125(1):127-47. doi: 10.1084/jem.125.1.127.
9
Mechanisms of immunologic injury of rat peritoneal mast cells. I. The effect of phosphonate inhibitors on the homocytotropic antibody-mediated histamine release and the first component of rat complement.大鼠腹膜肥大细胞免疫损伤机制。I. 膦酸盐抑制剂对亲同种细胞抗体介导的组胺释放及大鼠补体第一成分的影响。
J Exp Med. 1966 Sep 1;124(3):379-95. doi: 10.1084/jem.124.3.379.
10
Inhibitory effect of anti-allergic agent NCO-650 on histamine release induced by various secretagogues.抗过敏剂NCO - 650对多种促分泌素诱导的组胺释放的抑制作用。
Agents Actions. 1988 Aug;25(1-2):17-21. doi: 10.1007/BF01969088.

本文引用的文献

1
ISOLATION OF BETA IF-GLOBULIN FROM HUMAN SERUM AND ITS CHARACTERIZATION AS THE FIFTH COMPONENT OF COMPLEMENT.从人血清中分离β-免疫球蛋白并将其鉴定为补体的第五成分。
J Exp Med. 1965 Aug 1;122(2):277-98. doi: 10.1084/jem.122.2.277.
2
ESTIMATION OF THE SERUM BETA-1C GLOBULIN CONCENTRATION: ITS RELATION TO THE SERUM HEMOLYTIC COMPLEMENT TITER.血清β-1C球蛋白浓度的测定:其与血清溶血补体滴度的关系。
Pediatrics. 1965 May;35:765-9.
3
THE ENZYMATIC HYDROLYSIS OF P-NITROPHENYL ETHYL PHOSPHONATES BY MAMMALIAN PLASMAS.哺乳动物血浆对对硝基苯乙基膦酸酯的酶促水解作用
Biochem Pharmacol. 1964 Aug;13:1219-27. doi: 10.1016/0006-2952(64)90123-6.
4
A COMPARISON OF THE SPECIFICITY OF INHIBITION BY PHOSPHONATE ESTERS OF THE FIRST COMPONENT OF COMPLEMENT AND THE ANTIGEN-INDUCED RELEASE OF HISTAMINE FROM GUINEA PIG LUNG.膦酸酯对补体第一成分抑制特异性与抗原诱导豚鼠肺组织组胺释放的比较
J Exp Med. 1964 Oct 1;120(4):491-506. doi: 10.1084/jem.120.4.491.
5
THE MEASUREMENT OF SECOND COMPONENT OF HUMAN COMPLEMENT (C'2HU) BY ITS INTERACTION WITH EAC'1AGP,4GP CELLS.通过人补体第二成分(C'2HU)与EAC'1AGP,4GP细胞的相互作用对其进行测定
J Immunol. 1964 Jun;92:946-57.
6
ENZYME INHIBITORY ACTIVITY OF CERTAIN PHOSPHONATE ESTERS AGAINST CHYMOTRYPSIN, TRYPSIN AND ACETYLCHOLINESTERASE.某些膦酸酯对胰凝乳蛋白酶、胰蛋白酶和乙酰胆碱酯酶的酶抑制活性
Biochim Biophys Acta. 1964 Jun 1;85:441-5. doi: 10.1016/0926-6569(64)90308-6.
7
ANAPHYLAXIS IN ISOLATED RAT MAST CELLS. III. LOCALISATION OF THE CHYMOTRYPSIN-TYPE PROESTERASE IN HEAT-LABILE SERUM COMPONENTS.大鼠离体肥大细胞中的过敏反应。III. 胰凝乳蛋白酶型前酯酶在热不稳定血清成分中的定位。
Int Arch Allergy Appl Immunol. 1964;24:255-77.
8
THE MACROMOLECULAR NATURE OF THE FIRST COMPONENT OF HUMAN COMPLEMENT.人类补体第一成分的大分子性质
J Exp Med. 1964 Apr 1;119(4):593-613. doi: 10.1084/jem.119.4.593.
9
ISOLATION AND DESCRIPTION OF THE FOURTH COMPONENT OF HUMAN COMPLEMENT.人补体第四成分的分离与描述
J Exp Med. 1963 Sep 1;118(3):447-66. doi: 10.1084/jem.118.3.447.
10
Concerning the mechanism of complement action. IV. The properties of activated first component of guinea pig complement.关于补体作用机制。IV. 豚鼠补体激活的第一成分的特性。
J Immunol. 1959 Jan;82(1):43-51.